BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35963431)

  • 1. Impaired myocellular Ca
    Glaser D; Heinick A; Herting JR; Massing F; Müller FU; Pauls P; Rozhdestvensky TS; Schulte JS; Seidl MD; Skryabin BV; Stümpel F; Kirchhefer U
    J Biol Chem; 2022 Sep; 298(9):102362. PubMed ID: 35963431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates.
    Kirchhefer U; Brekle C; Eskandar J; Isensee G; Kučerová D; Müller FU; Pinet F; Schulte JS; Seidl MD; Boknik P
    J Biol Chem; 2014 Dec; 289(49):33862-73. PubMed ID: 25320082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PKC results in improved contractile effects and Ca
    Pluteanu F; Boknik P; Heinick A; König C; Müller FU; Weidlich A; Kirchhefer U
    Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H427-H441. PubMed ID: 35119335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivo.
    Puhl SL; Weeks KL; Güran A; Ranieri A; Boknik P; Kirchhefer U; Müller FU; Avkiran M
    Cardiovasc Res; 2019 Mar; 115(3):519-529. PubMed ID: 30203051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart.
    Little SC; Curran J; Makara MA; Kline CF; Ho HT; Xu Z; Wu X; Polina I; Musa H; Meadows AM; Carnes CA; Biesiadecki BJ; Davis JP; Weisleder N; Györke S; Wehrens XH; Hund TJ; Mohler PJ
    Sci Signal; 2015 Jul; 8(386):ra72. PubMed ID: 26198358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2.
    Terentyev D; Belevych AE; Terentyeva R; Martin MM; Malana GE; Kuhn DE; Abdellatif M; Feldman DS; Elton TS; Györke S
    Circ Res; 2009 Feb; 104(4):514-21. PubMed ID: 19131648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes.
    Zhang X; Tallini YN; Chen Z; Gan L; Wei B; Doran R; Miao L; Xin HB; Kotlikoff MI; Ji G
    Cardiovasc Res; 2009 Nov; 84(2):253-62. PubMed ID: 19578067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Phosphatase 2A Regulates Cardiac Na
    El Refaey M; Musa H; Murphy NP; Lubbers ER; Skaf M; Han M; Cavus O; Koenig SN; Wallace MJ; Gratz D; Bradley E; Alsina KM; Wehrens XHT; Hund TJ; Mohler PJ
    Circ Res; 2019 Mar; 124(5):737-746. PubMed ID: 30602331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic β-adrenergic stimulation reverses depressed Ca handling in mice overexpressing inhibitor-2 of protein phosphatase 1.
    Kirchhefer U; Hammer E; Heinick A; Herpertz T; Isensee G; Müller FU; Neumann J; Schulte K; Seidl MD; Boknik P; Schulte JS
    J Mol Cell Cardiol; 2018 Dec; 125():195-204. PubMed ID: 30389400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKII inhibition in heart failure, beneficial, harmful, or both.
    Cheng J; Xu L; Lai D; Guilbert A; Lim HJ; Keskanokwong T; Wang Y
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1454-65. PubMed ID: 22287581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
    Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
    J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model.
    Negroni JA; Morotti S; Lascano EC; Gomes AV; Grandi E; Puglisi JL; Bers DM
    J Mol Cell Cardiol; 2015 Apr; 81():162-75. PubMed ID: 25724724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Ca
    Kronenbitter A; Funk F; Hackert K; Gorreßen S; Glaser D; Boknik P; Poschmann G; Stühler K; Isić M; Krüger M; Schmitt JP
    J Mol Cell Cardiol; 2018 Jun; 119():28-39. PubMed ID: 29674140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholemman and beta-adrenergic stimulation in the heart.
    Wang J; Gao E; Song J; Zhang XQ; Li J; Koch WJ; Tucker AL; Philipson KD; Chan TO; Feldman AM; Cheung JY
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H807-15. PubMed ID: 20008271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during beta-adrenergic stimulation in mouse ventricular myocytes.
    Despa S; Tucker AL; Bers DM
    Circulation; 2008 Apr; 117(14):1849-55. PubMed ID: 18362230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted ablation of the histidine-rich Ca(2+)-binding protein (HRC) gene is associated with abnormal SR Ca(2+)-cycling and severe pathology under pressure-overload stress.
    Park CS; Chen S; Lee H; Cha H; Oh JG; Hong S; Han P; Ginsburg KS; Jin S; Park I; Singh VP; Wang HS; Franzini-Armstrong C; Park WJ; Bers DM; Kranias EG; Cho C; Kim DH
    Basic Res Cardiol; 2013 May; 108(3):344. PubMed ID: 23553082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric Oxide Modulates Ca
    Power AS; Asamudo EU; Worthington LPI; Alim CC; Parackal RE; Wallace RS; Ebenebe OV; Heller Brown J; Kohr MJ; Bers DM; Erickson JR
    Circ Res; 2023 Dec; 133(12):1040-1055. PubMed ID: 37961889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A.
    Taglieri DM; Monasky MM; Knezevic I; Sheehan KA; Lei M; Wang X; Chernoff J; Wolska BM; Ke Y; Solaro RJ
    J Mol Cell Cardiol; 2011 Dec; 51(6):988-96. PubMed ID: 21971074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced basal contractility but reduced excitation-contraction coupling efficiency and beta-adrenergic reserve of hearts with increased Cav1.2 activity.
    Tang M; Zhang X; Li Y; Guan Y; Ai X; Szeto C; Nakayama H; Zhang H; Ge S; Molkentin JD; Houser SR; Chen X
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H519-28. PubMed ID: 20543081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of protein phosphatase 2A regulatory subunit
    Pluteanu F; Glaser D; Massing F; Schulte JS; Kirchhefer U
    Front Cardiovasc Med; 2024; 11():1419597. PubMed ID: 38863902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.